Launch of VITALYFE ( AI-powered cardiometabolic) - Lupin Ltd

Code BSE: 500257 NSE:

Lupin Digital Health, India’s leading cardiac digital-therapeutics company, today announced the launch of VITALYFE™, an AI- powered cardiometabolic wellness platform designed to help India’s working professionals reclaim their heart health. Built on the foundation of LYFE — India’s first CDSCO-approved Class C software medical device (SaMD) for critical cardiac conditions VITALYFE™ extends hospital-grade cardiac expertise to preventive wellness for its users. “Cardiometabolic risks silently erode both health and productivity,” said Rajeev Sibal, President – India Region Formulations, Lupin. “With VITALYFE, we are enabling insurers and employers to combine clinical expertise with AI-driven technology to deliver scalable, measurable wellness outcomes for millions of working Indians.”